UK gov­ern­ment backs $189M ef­fort to bol­ster life sci; Bay­er files he­mo­phil­ia drug; Akcea files volane­sors­en NDA

⇨ With Brex­it loom­ing, the UK gov­ern­ment is par­tic­u­lar­ly anx­ious about pre­serv­ing and grow­ing its big bio­phar­ma sec­tor. With that in mind the gov­ern­ment has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER